Unknown

Dataset Information

0

TP53 mutations in epithelial ovarian cancer.

ABSTRACT: Genomic sequencing analyses of a variety of human cancers have revealed that massive mutations of cancer-relevant genes are the major alterations in cancerous cells, and their mutation frequencies or rates are highly associated with the development, progression, metastasis, and drug resistance of cancers as well as their clinical outcomes and prognosis. One predominant genetic alternation in human epithelial ovarian cancer (EOC) is the mutation of TP53 that encodes the tumor suppressor p53 protein. This essay will review the most recent progress in understanding the role of TP53 mutations in development, progression, and metastasis of EOC, and discuss the potential of TP53 mutations as diagnostic and prognostic biomarkers as well as therapeutic targets for EOC.

SUBMITTER: Zhang Y 

PROVIDER: S-EPMC6320227 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

TP53 mutations in epithelial ovarian cancer.

Zhang Yu Y   Cao Lan L   Nguyen Daniel D   Lu Hua H  

Translational cancer research 20161201 6

Genomic sequencing analyses of a variety of human cancers have revealed that massive mutations of cancer-relevant genes are the major alterations in cancerous cells, and their mutation frequencies or rates are highly associated with the development, progression, metastasis, and drug resistance of cancers as well as their clinical outcomes and prognosis. One predominant genetic alternation in human epithelial ovarian cancer (EOC) is the mutation of TP53 that encodes the tumor suppressor p53 prote  ...[more]

Similar Datasets

Unknown Optimization to detect TP53 mutations in circulating cell-free tumor DNA from patients with serous epithelial ovarian cancer.
| S-EPMC5956115 | biostudies-other
Unknown Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer.
| S-EPMC5626590 | biostudies-literature
Unknown Spectrum of TP53 Mutations in BRCA1/2 Associated High-Grade Serous Ovarian Cancer.
| S-EPMC7378769 | biostudies-literature
Unknown Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.
| S-EPMC2666150 | biostudies-literature
Unknown Expression signatures of TP53 mutations in serous ovarian cancers.
| S-EPMC2893110 | biostudies-literature
Unknown Oncogenic and drug-sensitive RET mutations in human epithelial ovarian cancer.
| S-EPMC7092606 | biostudies-literature
Unknown Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancer.
| S-EPMC4852274 | biostudies-literature
Unknown TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer.
| S-EPMC4538798 | biostudies-literature
Unknown Identification and clinical significance of somatic oncogenic mutations in epithelial ovarian cancer.
| S-EPMC8496016 | biostudies-literature
Unknown TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge.
| S-EPMC8087555 | biostudies-literature